Furanica Inc Profile last edited on: 10/2/2019
CAGE: 7SPF1
UEI: EXSNSDEFJVZ1
Business Identifier: Furan fatty acids (FuFAs): cardiovascular health protection nutraceuticals / pharmaceuticals 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
2731 Lillard Drive
Davis, CA 95618
Davis, CA 95618
| N/A |
| N/A |
| N/A |
Location: Single
Congr. District: 04
County: Yolo
Congr. District: 04
County: Yolo
Public Profile
Anchored in technology licensed from University of California Davis, Furanica Inc is involved in the development of furan fatty acids (FuFAs) These naturally occurring lipids in fish oils, are being examined as nutraceuticals and pharmaceuticals that could potentially be a factor is protecting cardiovascular health
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2023 | 1 | NIH | $299,169 | |
| Project Title: Structurally engineered furan fatty acids for the treatment of dyslipidemia and cardiovascular disease | ||||
| 2023 | 1 | NIH | $293,543 | |
| Project Title: Structurally engineered N-acyl amino acids for the treatment of NASH | ||||
| 2018 | 1 | NIH | $224,944 | |
| Project Title: Furan Fatty Acids (Fufas) as the Active Components of Fish Oils and Omega-3 Fatty Acid Products | ||||
Key People / Management
Fei Chang
Francisco Jose Schopfer
Francisco Jose Schopfer
Company News
There are no news available.
